Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUB-040 in Unresectable or Metastatic Nonsquamous Non-small Cell Lung Cancer
NCT07806773Phase 2Not yet recruiting
- Sponsor
- Tubulis
- Start
- Nov 2026
- Primary completion
- May 2029
- Countries
- 1
01
Overview
A Phase 2 trial of TUB-040 in non-small cell lung cancer (NSCLC), sponsored by Tubulis. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
TUB-040
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07806773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07806773.